{"id":12496,"date":"2022-10-07T09:22:00","date_gmt":"2022-10-07T09:22:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/3895833_AE95833_0"},"modified":"2022-10-07T09:22:00","modified_gmt":"2022-10-07T09:22:00","slug":"raffles-medical-group-and-nalagenetics-provide-pre-emptive-genetic-testing-for-adverse-drug-reactions","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=12496","title":{"rendered":"Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions"},"content":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png\" class=\"ff-og-image-inserted\"><\/div>\n<ul type=\"disc\">\n<li>Raffles is<span id=\"spanHghlt2a2b\">&nbsp;the fi<\/span>rst hospital in <span class=\"xn-location\">Singapore<\/span> to provide pre-emptive pharmacogenomics testing protocol<\/li>\n<li>Aims to reduce side effects due to inappropriate medications<\/li>\n<\/ul>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">SINGAPORE<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Oct. 7, 2022<\/span><\/span> \/PRNewswire\/ &#8212; Raffles Medical Group (RMG) is collaborating with biotech start-up NalaGenetics to offer pre-emptive pharmacogenomics testing at its hospital. It is the first hospital in <span class=\"xn-location\">Singapore<\/span> to provide such a service.<\/p>\n<p>Pharmacogenomics is the study of how genes affect a person&#8217;s response to medication. Pre-emptive pharmacogenomics testing on a healthy person can be used to discover whether a person is likely to respond well or develop adverse drug reactions (ADRs) to certain medications. The test results could then be used to guide doctors on the choice and dosage of medicine to improve patient <span id=\"spanHghltc0af\">outcomes<\/span>.<\/p>\n<p><b>Collaboration to conduct study &amp; offer commercial tests<\/b><\/p>\n<p>The collaboration between RMG and NalaGenetics involves the recruitment of 500 patients to participate in a pilot study on pre-emptive pharmacogenomics testing and covers a range of chronic prescriptions in cardiovascular, psychiatry and pain, among others. The study aims to better understand how doctors leverage such information, while providing research data on the potential benefits of large-scale implementation in <span class=\"xn-location\">Singapore<\/span>. The study will take place over one year and the recruitment starts on 3 October.<\/p>\n<p>Patients who suffer from or are prone to ten specified diseases will be eligible to take part in the study. Eligible participants will have their genetic samples collected via a non-invasive buccal swab at Raffles Hospital Singapore, which will then be tested by NalaGenetics in its laboratory. The test results will be integrated into the participants&#8217; electronic medical records at RMG. There is no cost involved to participate in the study.<\/p>\n<p>RMG will also avail the testing as a commercial service to other interested patients or members of the public, with NalaGenetics as the testing partner. Such commercial testing will cover a much wider range of medications.<\/p>\n<p><b>Benefits of pre-emptive pharmacogenomics testing <\/b><\/p>\n<p>Providing pre-emptive pharmacogenomics testing is timely as <span class=\"xn-location\">Singapore<\/span> is increasingly focusing on preventive health. Such testing could help to identify high-risk patients and avert side effects and even hospital admissions. For example, patients who have genetics that put them at risk of not being able to metabolise blood thinners well are up to two times more likely to experience recurring acute coronary syndrome<sup>[1]<\/sup>.&nbsp; Research has also shown that 8% of hospital admissions are caused by ADRs and 30% of those have high genetic associations, and patients with ADRs have a longer length of stay on average<sup>[2]<\/sup>.<\/p>\n<p>&#8220;RMG is the first hospital in <span class=\"xn-location\">Singapore<\/span> to offer pre-emptive pharmacogenomics testing. We believe that a patient&#8217;s genetic information can help facilitate our doctors&#8217; decision-making process and result in more appropriate prescriptions and better patient outcomes. As a leading integrated healthcare provider, we have always leveraged technology to enhance patient care, and this innovative collaboration with NalaGenetics is yet another value-added service for our patients,&#8221; says Dr. Chng Shih Kiat, Medical Director, Raffles Medical.<\/p>\n<p>&#8220;We believe that pre-emptive pharmacogenomics testing not just improves outcomes for patients, it also helps in cutting healthcare costs by avoiding inappropriate treatments. There are potentially long-term cost savings from implementing such pre-emptive testing on a large-scale for governments and insurance companies,&#8221; says Ms Levana Sani, CEO of NalaGenetics.<\/p>\n<p>She added, &#8220;This collaboration with RMG is very exciting for our team, because we get to implement our system end-to-end; from patient recruitment all the way to integration of patient reports to help physicians not only at the point of testing, but throughout the <span id=\"spanHghltab9b\">patient&#8217;s<\/span> health journey.&#8221;<\/p>\n<p>Those interested in taking the test can contact Raffles Health Screeners at Raffles Hospital.<\/p>\n<div>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"0\" class=\"prnbcc\">\n<tbody readability=\"2\">\n<tr readability=\"3\">\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\" readability=\"5\">\n<p class=\"prnml4\"><span class=\"prnews_span\">[1]&nbsp;https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.121.024159<\/span><\/p>\n<\/td>\n<\/tr>\n<tr readability=\"3\">\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\" readability=\"5\">\n<p class=\"prnml4\"><span class=\"prnews_span\">[2]&nbsp;https:\/\/pubmed.ncbi.nlm.nih.gov\/27640819\/ &nbsp;<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p><b>About Raffles Medical Group<\/b><\/p>\n<p>Raffles Medical Group (RMG) is a leading integrated private healthcare provider in <span class=\"xn-location\">Asia<\/span>, with presence in 14 cities across five countries. Through its network of more than 100 multi-disciplinary clinics and four hospitals, the Group provides its patients with a seamless continuum of care. Besides medical care, the Group&#8217;s comprehensive services include health insurance, healthcare training and consumer healthcare products. Established in 1976 with two clinics in <span class=\"xn-location\">Singapore<\/span>, the Group now has more than 2,700 employees, including close to 430 multi-specialty physicians, and serves over 2 million patients and 7,000 corporate clients a year. RMG is listed on the Singapore Exchange (SGX: BSL) since <span class=\"xn-chron\">April 1997<\/span>.<\/p>\n<p><b>About NalaGenetics<\/b><\/p>\n<p>NalaGenetics Pte Ltd is an A*STAR spinoff that focuses on the design and development of genetic analysis and interpretation tools. The company develops wet-lab and dry-lab solutions to enable personalized <span id=\"spanHghlta3d6\">prescriptions <\/span>and screening in hospitals and labs.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Raffles is&nbsp;the first hospital in Singapore to provide pre-emptive pharmacogenomics testing protocol Aims to reduce side effects due to inappropriate medications SINGAPORE, Oct. 7, 2022 \/PRNewswire\/ &#8212; Raffles Medical Group (RMG) is collaborating with biotech start-up NalaGenetics to offer pre-emptive pharmacogenomics testing at its hospital. It is the first hospital in Singapore to provide such [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-12496","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=12496\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions - My Blog\" \/>\n<meta property=\"og:description\" content=\"Raffles is&nbsp;the first hospital in Singapore to provide pre-emptive pharmacogenomics testing protocol Aims to reduce side effects due to inappropriate medications SINGAPORE, Oct. 7, 2022 \/PRNewswire\/ &#8212; Raffles Medical Group (RMG) is collaborating with biotech start-up NalaGenetics to offer pre-emptive pharmacogenomics testing at its hospital. It is the first hospital in Singapore to provide such [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=12496\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-07T09:22:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12496#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12496\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions\",\"datePublished\":\"2022-10-07T09:22:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12496\"},\"wordCount\":762,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12496#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12496\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12496\",\"name\":\"Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12496#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12496#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\",\"datePublished\":\"2022-10-07T09:22:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12496#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12496\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12496#primaryimage\",\"url\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\",\"contentUrl\":\"https:\\\/\\\/en.prnasia.com\\\/prnasia.com-PC\\\/images\\\/logo-en-blue-in.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=12496#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=12496","og_locale":"en_US","og_type":"article","og_title":"Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions - My Blog","og_description":"Raffles is&nbsp;the first hospital in Singapore to provide pre-emptive pharmacogenomics testing protocol Aims to reduce side effects due to inappropriate medications SINGAPORE, Oct. 7, 2022 \/PRNewswire\/ &#8212; Raffles Medical Group (RMG) is collaborating with biotech start-up NalaGenetics to offer pre-emptive pharmacogenomics testing at its hospital. It is the first hospital in Singapore to provide such [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=12496","og_site_name":"My Blog","article_published_time":"2022-10-07T09:22:00+00:00","og_image":[{"url":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=12496#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=12496"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions","datePublished":"2022-10-07T09:22:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=12496"},"wordCount":762,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=12496#primaryimage"},"thumbnailUrl":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=12496","url":"https:\/\/transmediavictoria.net.au\/?p=12496","name":"Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=12496#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=12496#primaryimage"},"thumbnailUrl":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","datePublished":"2022-10-07T09:22:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=12496#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=12496"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=12496#primaryimage","url":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png","contentUrl":"https:\/\/en.prnasia.com\/prnasia.com-PC\/images\/logo-en-blue-in.png"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=12496#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/12496","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12496"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/12496\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12496"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12496"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12496"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}